BackVycor Medical Overview
Vycor Medical, Inc.

Vycor Medical Return on Equity

Valuation check: VYCO's ROE is 1.45%, below the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

1.45%

Return on Equity

1.45%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Vycor Medical (VYCO) FAQ

The latest ROE for VYCO is 1.45%. That is below the sector sector average of 11.3%. Investors often review this figure alongside Vycor Medical's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, VYCO currently prints 1.45% for ROE, while the sector average sits near 11.3%. That is roughly 87.1% below the sector mean. Large gaps often invite a closer look at Vycor Medical's growth, margins, and balance sheet.

Return on Equity shows how effectively Vycor Medical converts resources into returns. At 1.45%, VYCO may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting VYCO's ROE (1.45%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.